Long-term Study to Evaluate Safety and Persistence of GF-CART01
Long-term Study to Evaluate Safety and Persistence of GF-CART01
Enrolling by invitation · NCT06985576 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Study to Evaluate Safety and Persistence of GF-CART01 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, histiocytosis, immune system disorder, immunoproliferative disorder, interdigitating dendritic cell sarcoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, neoplasm, primary mediastinal large B-cell lymphoma | Enrolling by invitation | Not stated | 2026-06-11 | NCT06985576 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GenomeFrontier Therapeutics TW Co., Ltd. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Taiwan University Hospital | Taipei | Taiwan | 174 |